Annals of Clinical and Translational Neurology (Apr 2022)

Novel CAPN1 missense variants in complex hereditary spastic paraplegia with early‐onset psychosis

  • Julian E. Alecu,
  • Afshin Saffari,
  • Hellen Jumo,
  • Marvin Ziegler,
  • Oleksandr Strelko,
  • Catherine A. Brownstein,
  • Joseph Gonzalez‐Heydrich,
  • Lance H. Rodan,
  • Mark P. Gorman,
  • Mustafa Sahin,
  • Darius Ebrahimi‐Fakhari

DOI
https://doi.org/10.1002/acn3.51531
Journal volume & issue
Vol. 9, no. 4
pp. 570 – 576

Abstract

Read online

Abstract CAPN1‐associated hereditary spastic paraplegia (SPG76) is a rare and clinically heterogenous syndrome due to loss of calpain‐1 function. Here we illustrate a translational approach to the case of an 18‐year‐old patient who first presented with psychiatric symptoms followed by spastic gait, intention tremor, and neurogenic bladder dysfunction, consistent with a complex form of HSP. Exome sequencing showed compound‐heterozygous missense variants in CAPN1 (NM_001198868.2: c.1712A>G (p.Asn571Ser)/c.1991C>T (p.Ser664Leu)) and a previously reported heterozygous stop‐gain variant in RCL1. In silico analyses of the CAPN1 variants predicted a deleterious effect and in vitro functional studies confirmed reduced calpain‐1 activity and dysregulated downstream signaling. These findings support a diagnosis of SPG76 and highlight that the psychiatric symptoms can precede the motor symptoms in HSP. Our results also suggest that multiple genes can potentially contribute to complex neuropsychiatric diseases.